Hollencrest Capital Management’s Biogen BIIB Stock Holding History

Hollencrest Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.81K	Hold	13	–	–	﹤0.01%	985
2026 Q1	$2.38K	Hold	13	–	–	﹤0.01%	1005
2025 Q4	$2.29K	Hold	13	–	–	﹤0.01%	1002
2025 Q3	$1.82K	Hold	13	–	–	﹤0.01%	999
2025 Q2	$1.63K	Hold	13	–	–	﹤0.01%	986
2025 Q1	$1.78K	Hold	13	–	–	﹤0.01%	977
2024 Q4	$1.99K	Hold	13	–	–	﹤0.01%	1015
2024 Q3	$2.52K	Hold	13	–	–	﹤0.01%	930
2024 Q2	$3.01K	Hold	13	–	–	﹤0.01%	893
2024 Q1	$2.8K	Hold	13	–	–	﹤0.01%	868
2023 Q4	$3.36K	Hold	13	–	–	﹤0.01%	848
2023 Q3	$3.34K	Hold	13	–	–	﹤0.01%	867
2023 Q2	$3.7K	Hold	13	–	–	﹤0.01%	894
2023 Q1	$3.61K	Sell	13 -200	-94%	-$55.3K	﹤0.01%	893
2022 Q4	$59K	Buy	+213	New	+$60.2K	0.01%	419
2015 Q2	–	Sell	-655	Closed	-$276K	–	433
2015 Q1	$276K	Sell	655 -7	-1%	-$2.76K	0.04%	296
2014 Q4	$225K	Buy	+662	New	+$214K	0.03%	349

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Hollencrest Capital Management's BIIB Position: Q2 2026 in Review

Hollencrest Capital Management held its Biogen (BIIB) position steady in Q2 2026 at 13 shares worth $2.81K. The position accounts for ﹤0.01% of the portfolio, ranked #985.

Hollencrest Capital Management first reported a position in BIIB in Q4 2014 and has held it in 17 quarters since. The position peaked at $276K in Q1 2015. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Hollencrest Capital Management held 13 shares of Biogen worth $2.81K as of Q2 2026.
Hollencrest Capital Management left its Biogen share count unchanged in Q2 2026.
Biogen made up ﹤0.01% of Hollencrest Capital Management's portfolio in Q2 2026, its #985 holding.
Hollencrest Capital Management first reported a position in Biogen in Q4 2014 and has held it in 17 quarters since.
Hollencrest Capital Management's Biogen position peaked at $276K in Q1 2015.
1,041 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Hollencrest Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.